Deregulation Phase II rolled out in January 2026, expands compliance reduction push: Economic Survey
State capacity is built not only through new institutions or additional controls, but through disciplined removal of frictions that impede productive activity. Phase II of deregulation launched in Jan ...
Apecotrep (BI 764198) is a potential first-in-class, oral, selective TRPC6 inhibitor being investigated as a novel, targeted, non-immunosuppressive therapy in people with primary focal segmental ...
Boehringer Ingelheim today announced results from a 12-week Phase II clinical trial evaluating apecotrep (BI 764198), an oral, potential first-in-class, non-immunosuppressive TRPC6 inhibitor for ...
Apecotrep (BI 764198) is a potential first-in-class, oral, selective TRPC6 inhibitor being investigated as a novel, targeted, non-immunosuppressive therapy in people with primary focal segmental ...
Maria W. Steenland, Brown University, Providence, Rhode Island. Laura R. Wherry ([email protected]), New York University, New York, New York. The Affordable Care Act (ACA) Medicaid expansions ...
This study will update and extend How People Learn: Brain, Mind, Experience, and School (2000) by examining the research that has emerged across various disciplines that focus on the study of learning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results